ALSO READ'My Hair For Cancer' a step towards creating cancer awareness: Priya Dutt Rs.3.5 crore contributed by IIFCL for Cancer Treatment 385 cancer patients benefit 'My Hair For Cancer' a step towards creating cancer awareness: Priya Dutt (Lead, correcting organisation's name) Asian Cancer Institute chosen best cancer hospital in India 70% cancer patients in India consult doctor at terminal stage (February 4 is World Cancer Day)
Indian drug major Dr Reddy's Laboratories on Friday announced it would sell Progesterone capsules in the US market for therapeutic treatment of cardiovascular disorders, breast cancer and probable dementia.
"The generic capsules, approved by the US Food and Drug Administration (USFDA), are a therapeutic equivalent version of Prometrium," said the city-based pharma company in a regulatory filing on the BSE.
Prometrium is a registered trademark of Abbvie Products LLC in the US.
"The capsules in 100mg and 200mg will be sold in bottle count size of 100," added the filing.
According to the healthcare industry information, services and technology provider IMS Health, the Prometrium brand and its generic capsules had sales valued at $153 million across the US in 12 months ending February.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)